{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:37:40Z","timestamp":1776749860050,"version":"3.51.2"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"crossref","award":["0"],"award-info":[{"award-number":["0"]}],"id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100013223","name":"PTC Therapeutics","doi-asserted-by":"publisher","award":["0"],"award-info":[{"award-number":["0"]}],"id":[{"id":"10.13039\/100013223","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Santhera Pharmaceuticals","award":["0"],"award-info":[{"award-number":["0"]}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","award":["0"],"award-info":[{"award-number":["0"]}],"id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1125-2","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T14:39:40Z","timestamp":1561387180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["De-duplicating patient records from three independent data sources reveals the incidence of rare neuromuscular disorders in Germany"],"prefix":"10.1186","volume":"14","author":[{"given":"Kirsten","family":"K\u00f6nig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Pechmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maggie C.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Schorling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Tassoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanns","family":"Lochm\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"M\u00fcller-Reible","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1618-7386","authenticated-orcid":false,"given":"Janbernd","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,24]]},"reference":[{"key":"1125_CR1","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/humu.22390","volume":"34","author":"CL Bladen","year":"2013","unstructured":"Bladen CL, Rafferty K, Straub V, Monges S, Moresco A, Dawkins H, et al. The TREAT-NMD Duchenne muscular dystrophy registries: conception, design, and utilization by industry and academia. Hum Mutat. 2013;34:1449\u201357. \n                    https:\/\/doi.org\/10.1002\/humu.22390\n                    \n                  .","journal-title":"Hum Mutat"},{"key":"1125_CR2","doi-asserted-by":"publisher","unstructured":"Baker D, Knoppers BM, Phillips M, van Enckevort D, Kaufmann P, Lochmuller H, Taruscio D. Privacy-preserving linkage of genomic and clinical data sets. IEEE\/ACM Trans Comput Biol Bioinform. 2018. \n                    https:\/\/doi.org\/10.1109\/TCBB.2018.2855125\n                    \n                  .","DOI":"10.1109\/TCBB.2018.2855125"},{"key":"1125_CR3","first-page":"31","volume":"223","author":"H Ebner","year":"2016","unstructured":"Ebner H, Hayn D, Falgenhauer M, Nitzlnader M, Schleiermacher G, Haupt R, et al. Piloting the European unified patient identity management (EUPID) concept to facilitate secondary use of neuroblastoma data from Clinical Trials and Biobanking. Stud Health Technol Inform. 2016;223:31\u20138.","journal-title":"Stud Health Technol Inform"},{"key":"1125_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-3-319-67144-4_5","volume":"1031","author":"R Thompson","year":"2017","unstructured":"Thompson R, Robertson A, Lochm\u00fcller H. Natural history, trial readiness and gene discovery: advances in patient registries for neuromuscular disease. Adv Exp Med Biol. 2017;1031:97\u2013124. \n                    https:\/\/doi.org\/10.1007\/978-3-319-67144-4_5\n                    \n                  .","journal-title":"Adv Exp Med Biol"},{"key":"1125_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/1750-1172-8-171","volume":"8","author":"S Rodger","year":"2013","unstructured":"Rodger S, Lochm\u00fcller H, Tassoni A, Gramsch K, K\u00f6nig K, Bushby K, et al. The TREAT-NMD care and trial site registry: an online registry to facilitate clinical research for neuromuscular diseases. Orphanet J Rare Dis. 2013;8:171. \n                    https:\/\/doi.org\/10.1186\/1750-1172-8-171\n                    \n                  .","journal-title":"Orphanet J Rare Dis"},{"key":"1125_CR6","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00415-017-8549-1","volume":"264","author":"IEC Verhaart","year":"2017","unstructured":"Verhaart IEC, Robertson A, Leary R, McMacken G, K\u00f6nig K, Kirschner J, et al. A multi-source approach to determine SMA incidence and research ready population. J Neurol. 2017;264:1465\u201373. \n                    https:\/\/doi.org\/10.1007\/s00415-017-8549-1\n                    \n                  .","journal-title":"J Neurol"},{"key":"1125_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13023-016-0424-0","volume":"11","author":"C Klug","year":"2016","unstructured":"Klug C, Schreiber-Katz O, Thiele S, Schorling E, Zowe J, Reilich P, et al. Disease burden of spinal muscular atrophy in Germany. Orphanet J Rare Dis. 2016;11:58. \n                    https:\/\/doi.org\/10.1186\/s13023-016-0424-0\n                    \n                  .","journal-title":"Orphanet J Rare Dis"},{"key":"1125_CR8","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/jcsm.12245","volume":"8","author":"MC Walter","year":"2017","unstructured":"Walter MC, Reilich P. Recent developments in Duchenne muscular dystrophy: facts and numbers. J Cachexia Sarcopenia Muscle. 2017;8:681\u20135. \n                    https:\/\/doi.org\/10.1002\/jcsm.12245\n                    \n                  .","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1125_CR9","doi-asserted-by":"publisher","first-page":"e101717","DOI":"10.1371\/journal.pone.0101717","volume":"9","author":"L Micallef","year":"2014","unstructured":"Micallef L, Rodgers P. eulerAPE: drawing area-proportional 3-Venn diagrams using ellipses. PLoS One. 2014;9:e101717. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0101717\n                    \n                  .","journal-title":"PLoS One"},{"key":"1125_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","volume":"12","author":"IEC Verhaart","year":"2017","unstructured":"Verhaart IEC, Robertson A, Wilson IJ, Aartsma-Rus A, Cameron S, Jones CC, et al. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review. Orphanet J Rare Dis. 2017;12:124. \n                    https:\/\/doi.org\/10.1186\/s13023-017-0671-8\n                    \n                  .","journal-title":"Orphanet J Rare Dis"},{"key":"1125_CR11","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","volume":"24","author":"JK Mah","year":"2014","unstructured":"Mah JK, Korngut L, Dykeman J, Day L, Pringsheim T, Jette N. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscul Disord. 2014;24:482\u201391. \n                    https:\/\/doi.org\/10.1016\/j.nmd.2014.03.008\n                    \n                  .","journal-title":"Neuromuscul Disord"},{"key":"1125_CR12","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13023-018-0918-z","volume":"13","author":"A Ambrosini","year":"2018","unstructured":"Ambrosini A, Calabrese D, Avato FM, Catania F, Cavaletti G, Pera MC, et al. The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage. Orphanet J Rare Dis. 2018;13:176. \n                    https:\/\/doi.org\/10.1186\/s13023-018-0918-z\n                    \n                  .","journal-title":"Orphanet J Rare Dis"},{"key":"1125_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/pch\/pxx125","volume":"23","author":"Y Wei","year":"2018","unstructured":"Wei Y, McCormick A, MacKenzie A, O'Ferrall E, Venance S, Mah JK, et al. The Canadian neuromuscular disease registry: connecting patients to national and international research opportunities. Paediatr Child Health. 2018;23:20\u20136. \n                    https:\/\/doi.org\/10.1093\/pch\/pxx125\n                    \n                  .","journal-title":"Paediatr Child Health"},{"key":"1125_CR14","doi-asserted-by":"publisher","unstructured":"Korinthenberg R. A new era in the management of Duchenne muscular dystrophy. Dev Med Child Neurol. 2018. \n                    https:\/\/doi.org\/10.1111\/dmcn.14129\n                    \n                  .","DOI":"10.1111\/dmcn.14129"},{"key":"1125_CR15","doi-asserted-by":"publisher","first-page":"175628561875450","DOI":"10.1177\/1756285618754501","volume":"11","author":"V Parente","year":"2018","unstructured":"Parente V, Corti S. Advances in spinal muscular atrophy therapeutics. Ther Adv Neurol Disord. 2018;11:1756285618754501. \n                    https:\/\/doi.org\/10.1177\/1756285618754501\n                    \n                  .","journal-title":"Ther Adv Neurol Disord"},{"key":"1125_CR16","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/s41431-017-0008-z","volume":"25","author":"H Lochm\u00fcller","year":"2017","unstructured":"Lochm\u00fcller H, Torrent I, Farnell J, Le Cam Y, Jonker AH, Lau LP, Baynam G, et al. The international rare diseases research consortium: policies and guidelines to maximize impact. Eur J Hum Genet. 2017;25:1293\u2013302. \n                    https:\/\/doi.org\/10.1038\/s41431-017-0008-z\n                    \n                  .","journal-title":"Eur J Hum Genet"},{"key":"1125_CR17","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41431-018-0115-5","volume":"26","author":"H Lochm\u00fcller","year":"2018","unstructured":"Lochm\u00fcller H, Badowska DM, Thompson R, Knoers NV, Aartsma-Rus A, Gut I, et al. RD-connect, NeurOmics and EURenOmics: collaborative European initiative for rare diseases. Eur J Hum Genet. 2018;26:778\u201385. \n                    https:\/\/doi.org\/10.1038\/s41431-018-0115-5\n                    \n                  .","journal-title":"Eur J Hum Genet"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1125-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1125-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1125-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T23:31:16Z","timestamp":1592868676000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1125-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,24]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1125"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1125-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,24]]},"assertion":[{"value":"13 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Of the central ethics committee has been obtained (Ethics Committee of the University of Freiburg, Germany (EK 546\/15)).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JK received research funding and\/or compensation for presentations and consultancy from Avexis, Biogen, Ionis Pharmaceuticals, Novartis, and Roche. HL received research funding and\/or compensation for presentations and consultancy from AMO Pharma, Biogen, Desitin, Roche, Santhera, Sarepta, Satellos, Ultragenyx. AP received compensations for presentations and training activities from Biogen. DS participated in workshops sponsored by Biogen. MCW received research funding and\/or compensation for presentations and consultancy from Avexis, Biogen, Gr\u00fcnenthal, Novartis, PTC, Roche, Santhera, and Sarepta.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}